Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Carole Huntsman Insider Profile
4 Followers
Carole Huntsman, CCO at Madrigal Pharmaceuticals, holds 10.79K shares in Madrigal Pharmaceuticals (Ticker: MDGL). Most recently, Carole Huntsman Sold $688 shares of Madrigal Pharmaceuticals on Nov 22, 2024 for an estimated value of 218.04K.
Carole Huntsman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Carole Huntsman's holdings
Insider Roles
CCO
Roles that Carole Huntsman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Carole Huntsman
Carole Huntsman's Trading History
List of latest transactions for each holding click on a transaction to see Carole Huntsman's performance on stock
You May Also Like
Carole Huntsman insider profile FAQ
What is the percentage of profitable transactions made by Carole Huntsman?
The percentage of profitable transactions made by Carole Huntsman is ―.
What is the average return per transaction made by Carole Huntsman?
The average return per transaction made by Carole Huntsman is ―.
What stocks does Carole Huntsman hold?
Carole Huntsman holds: MDGL stocks.
What was Carole Huntsman’s latest transaction?
Carole Huntsman latest transaction was an Informative Sell of $218.04K.
What was Carole Huntsman's most profitable transaction?
Carole Huntsman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Carole Huntsman's role in Madrigal Pharmaceuticals?
Carole Huntsman's role in Madrigal Pharmaceuticals is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.